Virtus Investment Advisers, Inc. Regenxbio Inc. Transaction History
Virtus Investment Advisers, Inc.
- $286 Million
- Q2 2025
A detailed history of Virtus Investment Advisers, Inc. transactions in Regenxbio Inc. stock. As of the latest transaction made, Virtus Investment Advisers, Inc. holds 9,219 shares of RGNX stock, worth $116,528. This represents 0.03% of its overall portfolio holdings.
Number of Shares
9,219
Previous 18,830
51.04%
Holding current value
$116,528
Previous $134,000
44.03%
% of portfolio
0.03%
Previous 0.05%
Shares
2 transactions
Others Institutions Holding RGNX
# of Institutions
183Shares Held
45.2MCall Options Held
103KPut Options Held
100K-
Black Rock Inc. New York, NY8.61MShares$109 Million0.0% of portfolio
-
Redmile Group, LLC San Francisco, CA4.78MShares$60.4 Million4.77% of portfolio
-
Jpmorgan Chase & CO New York, NY4.36MShares$55.2 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.42MShares$43.2 Million0.0% of portfolio
-
State Street Corp Boston, MA1.84MShares$23.3 Million0.0% of portfolio
About REGENXBIO Inc.
- Ticker RGNX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 43,230,000
- Market Cap $546M
- Description
- REGENXBIO Inc., a clinical-stage biotechnology company, provides gene therapy product candidates to deliver genes to cells to address genetic defects or to enable cells in the body to produce therapeutic proteins or antibodies that are intended to impact disease. Its gene therapy product candidates are based on NAV Technology Platform, a proprie...